Peeling Back The Layers: Exploring Veralto Through Analyst Insights
In the last three months, 4 analysts have published ratings on Veralto (NYSE:VLTO), offering a diverse range of perspectives from bullish to bearish.The table below summarizes their recent ratings,
Zurn Elkay Water Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/18/2024 8.11% Stifel $32 → $34 Maintains Hold 04/25/2024 14.47% Deutsche Bank $37 → $36 Maintains Buy 0
Veralto Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/18/2024 12.07% Stifel $100 → $110 Maintains Buy 06/14/2024 2.9% RBC Capital $101 → $101 Reiterates
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) fell sharply during Wednesday's session after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for
CECO Environmental Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/16/2024 14.86% Needham $26 → $34 Maintains Buy 05/01/2024 1.35% HC Wainwright & Co. $30 → $30
What's Going On With Upstart Stock?
Upstart Holdings, Inc. (NASDAQ:SPEC) shares are trading higher Monday. The stock rose 17% last week after it announced a new credit union partner.The Details:Upstart shares rose after the company